Biogen Inc. cleared one of the final regulatory hurdles for Avonex Monday when the us food and administration's advisory panel recommended the Injectable drug's approval, calling it safe and effective in treating multiple sclerosis.
Fda panel backs use of new drug to treat multiple sclerosis.